CGA
PRTA icon

Crescent Grove Advisors’s Prothena Corp PRTA Stock Holding History

Crescent Grove Advisors’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,000
Closed -$271K – 147
2017
Q2 		$271K Buy
+5,000
New +$266K 0.08% 107

Other funds holding PRTA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Crescent Grove Advisors's PRTA Position: Q3 2017 in Review

Crescent Grove Advisors sold out of Prothena Corp (PRTA) in Q3 2017, closing a stake of 5,000 shares — an estimated $271K sold.

Crescent Grove Advisors first reported a position in PRTA in Q2 2017 and held it in 1 quarter. The position peaked at $271K in Q2 2017. 153 funds tracked by Wall St. Rank hold PRTA as of Q3 2017.

  • Crescent Grove Advisors reported no remaining Prothena Corp position as of Q3 2017 after selling out during the quarter.
  • Crescent Grove Advisors sold 5,000 Prothena Corp shares in Q3 2017, an estimated $271K.
  • Crescent Grove Advisors first reported a position in Prothena Corp in Q2 2017 and held it in 1 quarter.
  • Crescent Grove Advisors's Prothena Corp position peaked at $271K in Q2 2017.
  • 153 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2017.

Based on Crescent Grove Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.